Thiotepa-based reduced intensity conditioning regimen: A 10 year followup

被引：17

作者：

Bacigalupo, A. ^{[1
]}

Raiola, A. M. ^{[1
]}

Lamparelli, T. ^{[1
]}

Gualandi, F. ^{[1
]}

Occhini, D. ^{[1
]}

Bregante, S. ^{[1
]}

Ibatici, A. ^{[1
]}

Di Grazia, C. ^{[1
]}

Dominietto, A. ^{[1
]}

Bruno, B. ^{[1
]}

Van Lint, M. T. ^{[1
]}

Frassoni, F. ^{[1
]}

机构：

[1] Osped San Martino Genova, Div Ematol 2, Genoa, Italy

来源：

BONE MARROW TRANSPLANTATION | 2007年 / 40卷 / 11期

关键词：

D O I：

10.1038/sj.bmt.1705863

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

引用

页码：1091 / 1093

页数：3

共 6 条

[1] Increasing use of reduced intensity conditioning transplants: report of the 2001 EBMT activity survey [J].

Gratwohl, A ;

Baldomero, H ;

Passweg, J ;

Urbano-Ispizua, A .

BONE MARROW TRANSPLANTATION, 2002, 30 (12) :813-831

[2] Transplant-lite:: Induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor cell transplantation as treatment for lymphoid malignancies [J].

Khouri, IF ;

Keating, M ;

Körbling, M ;

Przepiorka, D ;

Anderlini, P ;

O'Brien, S ;

Giralt, S ;

Ippoliti, C ;

von Wolff, B ;

Gajewski, J ;

Donato, M ;

Claxton, D ;

Ueno, N ;

Andersson, B ;

Gee, A ;

Champlin, R .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (08) :2817-2824

[3] One antigen mismatched related donor bone marrow transplant in a patient with acute lymphoblastic leukaemia and β-thalassaemia major:: potential cure of both marrow disorders [J].

Kottaridis, PD ;

Peggs, K ;

Lawrence, A ;

Verfuerth, S ;

Chatterjee, R ;

Telfer, P ;

Porter, JB ;

Mackinnon, S ;

Goldstone, AH .

BONE MARROW TRANSPLANTATION, 2000, 25 (06) :677-678

[4] Reduced intensity thiotepa-cyclophosphamide conditioning for allogeneic haemopoietic stem cell transplants (HSCT) in patients up to 60 years of age [J].

Raiola, AM ;

Van Lint, MT ;

Lamparelli, T ;

Gualandi, F ;

Mordini, N ;

Berisso, G ;

Bregante, S ;

Frassoni, F ;

Sessarego, M ;

Fugazza, G ;

Di Stefano, F ;

Pitto, A ;

Bacigalupo, A .

BRITISH JOURNAL OF HAEMATOLOGY, 2000, 109 (04) :716-721

[5] Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases [J].

Slavin, S ;

Nagler, A ;

Naparstek, E ;

Kapelushnik, Y ;

Aker, M ;

Cividalli, G ;

Varadi, G ;

Kirschbaum, M ;

Ackerstein, A ;

Samuel, S ;

Amar, A ;

Brautbar, C ;

Ben-Tal, O ;

Eldor, A ;

Or, R .

BLOOD, 1998, 91 (03) :756-763

[6] Mixed hematopoietic chimerism after marrow allografts - Transplantation in the ambulatory care setting [J].

Storb, R ;

Yu, C ;

Sandmaier, BM ;

McSweeney, PA ;

Georges, G ;

Nash, RA ;

Woolfrey, A .

HEMATOPOIETIC STEM CELLS: BIOLOGY AND TRANSPLANTATION, 1999, 872 :372-376

← 1 →